CSIMarket Company Name, Ticker, Competitors, else..
 
Mereo Biopharma Group Plc  (NASDAQ: MREO)
 

Mereo Biopharma Group Plc's Suppliers Performance

MREO's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
MREO Costs vs Sales of Suppliers Growth

• More on MREO Suppliers






Mereo Biopharma Group Plc's Comment on Supply Chain


Regulatory requirements for raw materials recognize their unique contamination risks and potential usage restrictions in certain countries. Approval from foreign regulatory authorities is necessary before initiating clinical trials or marketing products outside the United States, with approval processes differing by country. Non-clinical studies must adhere to Good Laboratory Practice (GLP) principles in accordance with EU Directive 2004/10/EC and OECD standards. Clinical trials conducted in the European Union are subject to EU and national regulations, International Council for Harmonisation Good Clinical Practice (ICH GCP) guidelines, and the ethical principles outlined in the Declaration of Helsinki. Sponsors located outside the EU are required to appoint an EU legal representative and provide clinical trial insurance and compensation. The EU Clinical Trials Regulation (CTR), effective January 31, 2022, standardizes the assessment and supervision of clinical trials across the EU via a centralized portal, replacing the previous directive that mandated separate applications in each member state.

Mereo Biopharma Group Plc's Comment on Supply Chain


Regulatory requirements for raw materials recognize their unique contamination risks and potential usage restrictions in certain countries. Approval from foreign regulatory authorities is necessary before initiating clinical trials or marketing products outside the United States, with approval processes differing by country. Non-clinical studies must adhere to Good Laboratory Practice (GLP) principles in accordance with EU Directive 2004/10/EC and OECD standards. Clinical trials conducted in the European Union are subject to EU and national regulations, International Council for Harmonisation Good Clinical Practice (ICH GCP) guidelines, and the ethical principles outlined in the Declaration of Helsinki. Sponsors located outside the EU are required to appoint an EU legal representative and provide clinical trial insurance and compensation. The EU Clinical Trials Regulation (CTR), effective January 31, 2022, standardizes the assessment and supervision of clinical trials across the EU via a centralized portal, replacing the previous directive that mandated separate applications in each member state.







MREO's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Mereo Biopharma Group Plc 271.20 36.46 -28.10 39
SUBTOTAL 0.00 0.00 0.00 -


Sources: Mereo Biopharma Group Plc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Mereo Biopharma Group Plc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.